开放支付数据库中眼科医生行业支付特征分析
基于美国医疗保险和医疗补助服务中心开放支付数据库2013年8月1日至2017年12月31日记录,分析美国眼科医生收到的行业支付特征。共20943名眼科医生收到736517笔支付,总额543679603.53美元,占数据库全部行业报告资金的1.67%。支付中位数22.44美元,大多数支付为食品和饮料,但资金主要流向研究(310142151.88美元,57.05%)和咨询费(73565327.71美元,13.51%)。
要点
- 共20943名眼科医生收到736517笔行业支付,总额543679603.53美元,占开放支付数据库全部资金的1.67%。
- 支付笔数最多为食品和饮料(581588笔,78.96%),资金最多为研究(310142151.88美元,57.05%)和咨询费(73565327.71美元,13.51%)。
- 每位眼科医生支付中位数为637.75美元(四分位距167.33-2065.54美元),加州为最高收入州(101135980.34美元,18.60%)。
核心结论
- 尽管无法核实这些报告的真实性,但研究结果表明眼科医生与行业之间的财务关系规模可观,这些关系可能增加医疗成本并影响医疗质量,但本研究未评估这些关联。
研究设计与样本
- 分析纳入2018年6月29日更新的美国医疗保险和医疗补助服务中心开放支付数据库数据,该数据库包含2013年8月1日至2017年12月31日行业报告的对医生和教学医院的支付公开记录。
- 纳入开放支付数据库中所有向美国眼科医生发放的一般性或研究性支付,按执业者、制造商、支付类别和地理位置进行汇总。
- 主要结局为美国或美国领土执业眼科医生所获支付的分布、数量和金额,同时评估支付类别、制造商、产品和地点的财务特征。
主要发现
- 开放支付数据库显示行业共报告20943名眼科医生收到736517笔支付,总额543679603.53美元,占开放支付数据库中所有行业报告资金的1.67%。
- 支付金额中位数为22.44美元,大多数支付为食品和饮料(581588笔,78.96%),而大多数资金分配至研究(310142151.88美元,57.05%)和咨询费(73565327.71美元,13.51%)。
- 每位眼科医生所获支付中位数为637.75美元(四分位距167.33-2065.54美元),加州为收入最高的州,收到101135980.34美元(18.60%)。
- 15家公司承担了全部资金的87.68%(476719470.11美元),主要涉及药品(抗血管内皮生长因子药物、青光眼滴眼液和眼部润滑剂)及手术器械(白内障和青光眼)的生产。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文指出无法核实这些报告的真实性。
- 原文指出这些关系可能增加医疗成本并影响医疗质量,但本研究未评估这些关联。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: An increased awareness of the interactions between the medical industry and health care professionals may lead to lower health care costs and more effective health care practices. OBJECTIVE: To assess the characteristics of industry payments made to ophthalmologists between 2013 and 2017. DESIGN, SETTING, AND PARTICIPANTS: This analysis included data reported in the June 29, 2018, update of the Centers for Medicare & Medicaid Services Open Payments Database (OPD). The OPD contains public records of industry payments made to physicians and teaching hospitals from August 1, 2013, to December 31, 2017, as reported by the medical industry. All general or research payments distributed to US ophthalmologists and contained in the OPD were included in this study. Data are summarized by practitioner, manufacturer, payment category, and geographic location. MAIN OUTCOMES AND MEASURES: Main outcomes were the distribution, quantity, and value of payments made to ophthalmologists practicing in the United States or US territories. The financial characteristics of payment category, manufacturer, product, and location were also assessed. RESULTS: This analysis revealed that the OPD showed industry reporting a total of 20 943 ophthalmologists receiving 736 517 payments worth $543 679 603.53 (1.67% of all industry-reported funds in the OPD). The median payment value was $22.44. Most payments were for food and beverages (581 588 [78.96%]), whereas most funds were allocated toward research ($310 142 151.88 [57.05%]) and consulting fees ($73 565 327.71 [13.51%]). The median payout to each ophthalmologist was $637.75 (interquartile range, $167.33-$2065.54). California was the highest-grossing state, receiving $101 135 980.34 (18.60%) of all payments. Fifteen companies were responsible for 87.68% of all funds distributed ($476 719 470.11) and were mostly involved in the production of pharmaceutical agents (anti-vascular endothelial growth factor agents, glaucoma eyedrops, and ocular lubricants) and surgical devices (cataract and glaucoma). CONCLUSIONS AND RELEVANCE: Although there is no way to know the veracity of these reports, the findings suggest the financial ophthalmologist-industry relationship is substantial. These relationships may be adding to health care costs and affecting the quality of care, although those associations were not evaluated in this study.
引用
- Slentz DH, Nelson CC, Lichter PR, et al. Characteristics of Industry Payments to Ophthalmologists in the Open Payments Database. JAMA Ophthalmol. 2019. PMID: 31268495. doi:10.1001/jamaophthalmol.2019.2456
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。